Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
about
Primary graft dysfunction: lessons learned about the first 72 h after lung transplantationShear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation.Advanced therapies for COPD-What's on the horizon? Progress in lung volume reduction and lung transplantationRecipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis.Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantationPlasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction RiskEarly plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndromeIncreased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung TransplantationDiastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung TransplantEffects of intraoperative inhaled iloprost on primary graft dysfunction after lung transplantation: A retrospective single center study.Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea.Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.Primary graft dysfunction.CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.A review of bronchiolitis obliterans syndrome and therapeutic strategies.Lung Transplantation in Patients With Systemic Sclerosis.Mid-term results of bilateral lung transplant with postoperatively extended intraoperative extracorporeal membrane oxygenation for severe pulmonary hypertension.Successful emergent lung transplantation after remote ex vivo perfusion optimization and transportation of donor lungs.Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction After Lung Transplant.Pulmonary hypertension as a risk factor of mortality after lung transplantation.Ex-vivo recruitment and x-ray assessment of donor lungs in a challenging retrieval from a donor supported by lvad using the portable normothermic perfusion system: a case report.IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation.Fractal circuit sensors enable rapid quantification of biomarkers for donor lung assessment for transplantationRetrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience.Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury.Ex vivo administration of trimetazidine improves post-transplant lung function in pig model.Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.High Emergency Lung Transplantation: dramatic decrease of waiting list death rate without relevant higher post-transplant mortality.Short-term outcomes of lung transplant in idiopathic pulmonary fibrosisLung volume reduction followed by lung transplantation-considerations on selection criteria and outcome
P2860
Q28084783-C6CFABBC-8805-42AF-97AF-AF28914028C6Q34439910-4F61317B-28C0-494E-9C33-451C8557EA4EQ34628616-49506F9A-DAC5-4E49-BC36-66CB00AEF4F7Q35127935-A34C328B-E5D9-41B8-9B06-2C8C7285D7A3Q35153485-2C6929CB-E8DF-499C-AA86-591C8E3B4ACDQ36030924-8B589695-6FC2-4F0A-85BA-389830C1AFC0Q36162053-822F7964-6D82-463D-9FE3-EA3C48669256Q36405808-063A23E4-0181-4629-AF2D-17AC51CE6308Q36619643-08C35686-3B11-4533-89CD-6ECC10185CC1Q36640118-0A375591-C547-4646-AC1E-2AC1D57175F6Q36709286-0FEB8C3D-97AB-4877-B390-2BCA264AE93DQ37013126-F7E71571-4C7E-4438-996B-0038C8B038F3Q37327905-8BE1D62E-61FB-43D7-95C9-858E009C53DBQ37528243-D93B5EAA-7483-48E2-B2E5-4D2F4077A46FQ37638592-AE8428F5-B776-4EA6-AE00-3CB95D1371B7Q37670609-8E2BE70E-C77E-4590-922E-8FF848EA7E61Q37671669-87023C1B-ABC6-41C5-A12D-63D6F3C74FAFQ37902258-049ABE3C-0436-4B8F-A521-C228D91E6709Q38733776-DBD1133D-2F99-417C-B42A-B3E47297023CQ38886414-B10D7827-2AE6-45DC-A52B-C51983997123Q39223375-649CBA95-B87C-49FB-B05D-5682A4566844Q39343558-C7F58FF1-A1EB-4E1F-B1B6-840C8FD769AEQ40057755-99223A23-AD7F-4985-B3B9-00F2D1D8E482Q40967652-1869FA4C-B9F0-42C1-81C1-23CD2C6B76E9Q42256209-92EA808A-D6B8-4269-B6AF-71F92F677000Q42364236-BA80B4CC-FBCD-43E4-9BEC-53C892EA4A2AQ42619940-ADC85C79-6FA0-4227-85A5-E58B0184DC8AQ45243128-4DC90DEF-B78E-4E52-96ED-B36A85F3BDF7Q47309985-FAC07800-CAAC-4C9A-8AAC-3C1A624A9228Q47853008-8DAEB2DE-1FBE-449C-BE1A-991D5BC93267Q48149931-66F411A7-2089-4081-8EB8-2F1C25D60AB8Q50978946-EBBFC1D9-25DE-4B66-98EB-3F11DA28622DQ57717858-D30D2AE0-0431-4E56-8F54-A06FC06B653FQ59137563-312B37BD-DA00-4E94-BC85-25F9DB66619A
P2860
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@en
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@nl
type
label
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@en
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@nl
prefLabel
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@en
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@nl
P2093
P356
P1476
Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.
@en
P2093
James C Lee
Jason D Christie
Shaf Keshavjee
P304
P356
10.1055/S-0030-1249111
P577
2010-03-30T00:00:00Z